Bufalin, a component in Chansu, inhibits proliferation and invasion of hepatocellular carcinoma cells

BACKGROUND: Hepatocellular carcinoma (HCC) is a common and aggressive cancer, and the treatment options are limited for patients with advanced HCC. Bufalin, the major digoxin-like component of the traditional Chinese medicine Chansu, exhibits significant anti-tumor activities in many tumor cell line...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Dong-Ze, Zhang, Zhou-Ji, Wu, Wei-Zhong, Yang, Yun-Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723921/
https://www.ncbi.nlm.nih.gov/pubmed/23870199
http://dx.doi.org/10.1186/1472-6882-13-185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723921/
https://www.ncbi.nlm.nih.gov/pubmed/23870199
http://dx.doi.org/10.1186/1472-6882-13-185

Ejemplares similares